# Migraine Prevention Using ActiPatch

> **NCT03166046** · NA · COMPLETED · sponsor: **BioElectronics Corporation** · enrollment: 45 (actual)

## Conditions studied

- Migraine

## Interventions

- **DEVICE:** Pulsed Shortwave Therapy
- **DEVICE:** Placebo Pulsed Shortwave therapy

## Key facts

- **NCT ID:** NCT03166046
- **Lead sponsor:** BioElectronics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2018-04-01
- **Final completion:** 2018-04-30
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2018-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03166046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03166046, "Migraine Prevention Using ActiPatch". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03166046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*